Literature DB >> 12374673

Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer.

Andreas Widschwendter1, Sibylle Tonko-Geymayer, Thomas Welte, Günter Daxenbichler, Christian Marth, Wolfgang Doppler.   

Abstract

PURPOSE: Signal transducers and activators of transcription (STATs)were shown to be activated in mammary carcinoma. Because different STAT factors are likely to have different functions in these tumors, an assessment of their individual role is mandatory. EXPERIMENTAL
DESIGN: In this study we have separately determined activation of STAT1, STAT3, and STAT5 by measuring their DNA binding activity and tyrosine phosphorylation in breast cancer tissue samples. The predictive value of STAT activation on relapse-free and overall survival among women who received treatment for primary breast cancer was evaluated in a retrospective study.
RESULTS: Survival analysis demonstrated that patients with high STAT1 activation have substantially longer overall and relapse-free survival, irrespective of whether STAT1 activation was determined by its DNA binding activity (P = 0.003 and 0.010, respectively) or by its tyrosine phosphorylation (P = 0.046 and 0.011, respectively). In accordance, Cox proportional hazard regression analysis revealed an enhanced hazard of death (hazard ratio, 3.77; P = 0.018) and relapse of disease (hazard ratio, 6.55; P = 0.013) for the group of women with low STAT1 activation. After adjusting for known prognostic variables (lymph node status, stage of disease, estrogen receptor status, and cathepsin D), STAT1 activation remained an independent prognostic value. Activation of STAT3 and STAT5 DNA binding did not significantly correlate with prognosis.
CONCLUSION: Our study reveals a favorable and independent prognostic significance of STAT1 activation in mammary carcinoma, and is in accordance with the documented role of STAT1 in growth arrest, and in pro-apoptotic signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12374673

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  44 in total

1.  Stromal retinoic acid receptor beta promotes mammary gland tumorigenesis.

Authors:  Xingxing Liu; Mélanie Nugoli; Julie Laferrière; Sadiq M Saleh; Ian G Rodrigue-Gervais; Maya Saleh; Morag Park; Michael T Hallett; William J Muller; Vincent Giguère
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

Review 2.  Roles and regulation of stat family transcription factors in human breast cancer.

Authors:  Charles V Clevenger
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

Review 3.  Antitumour actions of interferons: implications for cancer therapy.

Authors:  Belinda S Parker; Jai Rautela; Paul J Hertzog
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

Review 4.  Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models.

Authors:  Katherine A Leehy; Thu H Truong; Laura J Mauro; Carol A Lange
Journal:  J Steroid Biochem Mol Biol       Date:  2017-04-23       Impact factor: 4.292

5.  Identification of molecular markers for metastasis-related genes in primary breast cancer cells.

Authors:  Koshi Mimori; Akemi Kataoka; Keiji Yoshinaga; Mitsuhiko Ohta; Yasuaki Sagara; Yasuji Yoshikawa; Shinji Ohno; Graham F Barnard; Masaki Mori
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

6.  Parallel analysis of transcript and translation profiles: identification of metastasis-related signal pathways differentially regulated by drug and genetic modifications.

Authors:  Haiyan Yang; Li-Rong Yu; Ming Yi; David A Lucas; Luanne Lukes; Mindy Lancaster; King C Chan; Haleem J Issaq; Robert M Stephens; Thomas P Conrads; Timothy D Veenstra; Kent W Hunter
Journal:  J Proteome Res       Date:  2006-07       Impact factor: 4.466

Review 7.  STAT signaling in mammary gland differentiation, cell survival and tumorigenesis.

Authors:  S Haricharan; Y Li
Journal:  Mol Cell Endocrinol       Date:  2013-03-28       Impact factor: 4.102

Review 8.  Transcriptional control of the cell cycle in mammary gland development and tumorigenesis.

Authors:  Ricardo D Coletta; Paul Jedlicka; Arthur Gutierrez-Hartmann; Heide L Ford
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

9.  Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C.

Authors:  Tobias N Dechow; Laura Pedranzini; Andrea Leitch; Kenneth Leslie; William L Gerald; Irina Linkov; Jacqueline F Bromberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

10.  The milk protein α-casein functions as a tumor suppressor via activation of STAT1 signaling, effectively preventing breast cancer tumor growth and metastasis.

Authors:  Gloria Bonuccelli; Remedios Castello-Cros; Franco Capozza; Ubaldo E Martinez-Outschoorn; Zhao Lin; Aristotelis Tsirigos; Jiao Xuanmao; Diana Whitaker-Menezes; Anthony Howell; Michael P Lisanti; Federica Sotgia
Journal:  Cell Cycle       Date:  2012-10-09       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.